Monalizumab and trastuzumab in metastatic HER2-positive breast cancer: MIMOSA-trial

Geurts, VCM; Voorwerk, L; Sikorska, K; Van Dongen, MG; Kemper, I; Mandjes, IAM; Haanen, JBAG; Sonke, GS; Kok, M

ANNALS OF ONCOLOGY, 2021; 32 (): S59